VOYA Investment Management
IMVT icon

VOYA Investment Management’s Immunovant IMVT Stock Holding History

VOYA Investment Management’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.39M Buy
87,993
+33,707
+62% +$1.03M ﹤0.01% 1025
2026
Q1 		$1.35M Buy
54,286
+655
+1% +$17K ﹤0.01% 1354
2025
Q4 		$1.36M Buy
53,631
+40,980
+324% +$914K ﹤0.01% 1372
2025
Q3 		$204K Sell
12,651
-5,940
-32% -$96.2K ﹤0.01% 2183
2025
Q2 		$297K Sell
18,591
-15,478
-45% -$234K ﹤0.01% 2153
2025
Q1 		$582K Sell
34,069
-1,792
-5% -$37.5K ﹤0.01% 1799
2024
Q4 		$888K Sell
35,861
-1,325
-4% -$37.6K ﹤0.01% 1654
2024
Q3 		$1.06M Sell
37,186
-27,860
-43% -$822K ﹤0.01% 1609
2024
Q2 		$1.72M Sell
65,046
-15,864
-20% -$451K ﹤0.01% 1363
2024
Q1 		$2.61M Sell
80,910
-3,847
-5% -$140K ﹤0.01% 1253
2023
Q4 		$3.57M Sell
84,757
-22,796
-21% -$839K ﹤0.01% 1132
2023
Q3 		$4.13M Buy
107,553
+86,174
+403% +$1.95M ﹤0.01% 1051
2023
Q2 		$406K Buy
21,379
+4,564
+27% +$85.1K ﹤0.01% 2201
2023
Q1 		$261K Hold
16,815
– – ﹤0.01% 2396
2022
Q4 		$298K Buy
16,815
+1,398
+9% +$17.6K ﹤0.01% 2335
2022
Q3 		$86K Hold
15,417
– – ﹤0.01% 2812
2022
Q2 		$60K Hold
15,417
– – ﹤0.01% 2715
2022
Q1 		$85K Hold
15,417
– – ﹤0.01% 2533
2021
Q4 		$131K Buy
15,417
+135
+0.9% +$1.11K ﹤0.01% 2621
2021
Q3 		$133K Hold
15,282
– – ﹤0.01% 2678
2021
Q2 		$162K Sell
15,282
-1,933
-11% -$27K ﹤0.01% 2664
2021
Q1 		$276K Buy
17,215
+1,377
+9% +$36.3K ﹤0.01% 2356
2020
Q4 		$732K Buy
15,838
+4,140
+35% +$191K ﹤0.01% 1677
2020
Q3 		$412K Buy
+11,698
New +$352K ﹤0.01% 1778

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

VOYA Investment Management's IMVT Position: Q2 2026 in Review

VOYA Investment Management increased its Immunovant (IMVT) stake by 62% in Q2 2026, buying an estimated $1.03M and bringing the position to 87,993 shares worth $3.39M. The position accounts for ﹤0.01% of the portfolio, ranked #1025.

VOYA Investment Management first reported a position in IMVT in Q3 2020 and has held it in 24 quarters since. The position peaked at $4.13M in Q3 2023. 226 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

  • VOYA Investment Management held 87,993 shares of Immunovant worth $3.39M as of Q2 2026.
  • VOYA Investment Management bought 33,707 Immunovant shares in Q2 2026, an estimated $1.03M.
  • Immunovant made up ﹤0.01% of VOYA Investment Management's portfolio in Q2 2026, its #1025 holding.
  • VOYA Investment Management first reported a position in Immunovant in Q3 2020 and has held it in 24 quarters since.
  • VOYA Investment Management's Immunovant position peaked at $4.13M in Q3 2023.
  • 226 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.